Activation of p38 mitogen-activated protein kinase attenuates Leishmania donovani infection in macrophages

Junghae, M; Raynes, JG; (2002) Activation of p38 mitogen-activated protein kinase attenuates Leishmania donovani infection in macrophages. Infection and immunity, 70 (9). pp. 5026-35. ISSN 0019-9567 DOI:

Full text not available from this repository. (Request a copy)


Leishmania-induced macrophage dysfunctions have been correlated with altered signaling events. In this work, we report that SB203580, a specific inhibitor of p38 mitogen-activated protein kinases (MAPK), increases Leishmania donovani survival in human peripheral blood mononuclear macrophages. Consistent with this finding, activation of p38 and c-jun N-terminal kinase (JNK) MAPK signaling pathways by anisomycin significantly reduced parasite survival within these cells. However, the majority of the effect was seen in a 50% reduction in the percentage of macrophages infected, with little effect on the highly infected macrophages. The observed effect was likely to be due to the p38 MAPK pathway since SB203580 was able to completely reverse the effect of anisomycin. These findings suggest that the previously reported p38 MAPK inhibition by Leishmania infection may be partially overcome by anisomycin. Similar effects were observed in pretreated macrophages or in treatment of infected macrophages. These results suggests that p38 MAPK activation may have a potential therapeutic value in the treatment of visceral leishmaniasis.

Item Type: Article
Keywords: Animal, Anisomycin/pharmacology, Antiprotozoal Agents/pharmacology, Enzyme Activation, Enzyme Inhibitors/pharmacology, Human, Imidazoles/pharmacology, In Vitro, Leishmania donovani/*drug effects/*pathogenicity, Leishmaniasis, Visceral/drug therapy/enzymology/parasitology, Lipopolysaccharides/pharmacology, Macrophages/drug effects/*enzymology/immunology/*parasitology, Mitogen-Activated Protein Kinases/antagonists & inhibitors/*metabolism, Phosphorylation, Pyridines/pharmacology, Signal Transduction/drug effects, Support, Non-U.S. Gov't, Animal, Anisomycin, pharmacology, Antiprotozoal Agents, pharmacology, Enzyme Activation, Enzyme Inhibitors, pharmacology, Human, Imidazoles, pharmacology, In Vitro, Leishmania donovani, drug effects, pathogenicity, Leishmaniasis, Visceral, drug therapy, enzymology, parasitology, Lipopolysaccharides, pharmacology, Macrophages, drug effects, enzymology, immunology, parasitology, Mitogen-Activated Protein Kinases, antagonists & inhibitors, metabolism, Phosphorylation, Pyridines, pharmacology, Signal Transduction, drug effects, Support, Non-U.S. Gov't
Faculty and Department: Faculty of Infectious and Tropical Diseases > Dept of Immunology and Infection
Research Centre: Leishmaniasis Group
PubMed ID: 12183549
Web of Science ID: 177491100034


Download activity - last 12 months
Downloads since deposit
Accesses by country - last 12 months
Accesses by referrer - last 12 months
Impact and interest
Additional statistics for this record are available via IRStats2

Actions (login required)

Edit Item Edit Item